Manufacturer record
Medibios Laboratories Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Medibios Laboratories Pvt. Ltd (Maharashtra) were declared Not of Standard Quality in October 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MBD0214, New Erythrocin 500 (Erythromycin Stearate Tablets I.P. 500 mg) (exp Apr 2020). CDL Kolkata (CDSCO lab) found it not of standard quality: Dissolution. Listed in the October 2019 alert.
Records by type
2 records linked to Medibios Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| New Erythrocin 500 (Erythromycin Stearate Tablets I.P. 500 mg) | Batch MBD0214Mfg Nov 2018 · Exp Apr 2020 | DissolutionDissolution | CDL KolkataCDSCO lab | Oct 2019 |
| Erythrocin 500 (Erythromycin Stearate Tablets I.P. 500 mg) | Batch MBE0082Mfg May 2019 · Exp Apr 2021 | DissolutionDissolution | CDL KolkataCDSCO lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.